Trending stocks

Godrej Consumer Products reports 19.4% Net Income growth and 1.1 pp EBITDA Margin growth from 15.5% to 16.6%

28-04-2015 • About Godrej Consumer Products ($GODREJCP) • By InTwits

Godrej Consumer Products reported FY2015 financial results today. Overall the company's long term financial model is characterised by the following facts:
  • Godrej Consumer Products has medium CAPEX intensity: 5 year average CAPEX/Revenue was 9.9%. At the same time it's a lot of higher than industry average of 5.7%.
  • CAPEX is quite volatile: 2,126 in FY2015, 1,329 in FY2014, 2,636 in FY2013, 1,565 in FY2012, 13,880 in FY2011
  • The company has highly profitable business model: ROIC is at 18.8%
  • It operates with high leverage: Net Debt/EBITDA is 1.7x while industry average is 0.5x
Below you can find a comprehensive analysis of the key data driving the company's performance and stock price.

Godrej Consumer Products ($GODREJCP) key annual financial indicators

mln. INR201120122013201420152015/2014
P&L
Revenue36,76348,50963,90875,82682,4228.7%
EBITDA6,5318,75910,15211,77113,68616.3%
Net Income5,1477,2677,9617,5979,07119.4%
Balance Sheet
Cash2,2694,6407,5966,3534,127-35.0%
Short Term Debt6,5873,4885,9027,8266,941-11.3%
Long Term Debt13,42015,28118,66215,90320,23027.2%
Cash flow
Capex13,8801,5652,6361,3292,12660.0%
Ratios
Revenue growth-61.4%32.0%31.7%18.6%8.7%
EBITDA growth59.4%34.1%15.9%16.0%16.3%
EBITDA Margin17.8%18.1%15.9%15.5%16.6%1.1%
Net Income Margin14.0%15.0%12.5%10.0%11.0%1.0%
CAPEX, % of revenue37.8%3.2%4.1%1.8%2.6%0.8%
ROIC25.5%19.1%17.4%17.7%18.8%1.1%
ROE38.4%32.1%26.0%21.4%22.4%1.0%
Net Debt/EBITDA2.7x1.6x1.7x1.5x1.7x0.2x

Revenue and profitability


The company's Revenue increased on 8.7% in FY2015. Having declining revenue the company managed to increase EBITDA margin. EBITDA Margin increased on 7.4 pp from -1.3% to 6.1% in FY2015.

Net Income marign increased slightly on 0.99 pp from 10.0% to 11.0% in FY2015.

Capital expenditures (CAPEX) and working capital investments


In FY2015 Godrej Consumer Products had CAPEX/Revenue of 2.6%. Godrej Consumer Products's CAPEX/Revenue decreased slightly on 0.65 pp from 3.2% in FY2012 to 2.6% in FY2015. For the last three years the average CAPEX/Revenue was 2.8%.

Return on investment


The company operates at high and attractive ROE (22.44%) while ROIC is a bit lower (18.79%). ROIC increased slightly on 1.1 pp from 17.7% to 18.8% in FY2015. ROE increased slightly on 1.0 pp from 21.4% to 22.4% in FY2015.

Leverage (Debt)


Company's Net Debt / EBITDA is 1.7x and Debt / EBITDA is 2.0x. Net Debt / EBITDA jumped on 0.2x from 1.5x to 1.7x in FY2015. Debt jumped on 14.5% in FY2015 while cash dropped on 35.0% in FY2015.

Valuation


The company's trades at EV/EBITDA 29.0x and P/E 41.2x while industy averages are 10.5x and 26.1x. Godrej Consumer Products's EV/(EBITDA-CAPEX) is 34.3x with the industry average at 4.7x.

Appendix 1: Peers in Personal Products


Below we provide Godrej Consumer Products benchmarking against other companies in Personal Products industry for the last 5 years. We show data for the top-5 companies by key financial metric together with the median value for all the companies in the industry.

Top companies by Revenue growth, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Procter & Gamble Hygiene & Health Care ($PGHH)-65.3%29.4%29.9%21.5%
Dabur India ($DABUR)-56.2%29.3%16.3%15.0%
Colgate-Palmolive (India) ($COLPAL)-55.8%17.8%17.5%13.1%
Hindustan Unilever ($HINDUNILVR)-60.1%17.0%14.5%8.4%
Emami ($EMAMILTD)-53.7%16.6%16.9%7.2%
 
Median (7 companies)-56.0%22.4%16.9%8.4%
Godrej Consumer Products ($GODREJCP)32.0%31.7%18.6%8.7%


Top companies by EBITDA margin, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Emami ($EMAMILTD)21.8%20.9%20.5%24.3%
Bliss Gvs Pharma ($BLISSGVS)27.2%28.1%20.9%
Procter & Gamble Hygiene & Health Care ($PGHH)16.6%16.3%15.4%20.7%
Colgate-Palmolive (India) ($COLPAL)22.6%21.7%21.0%18.6%
Hindustan Unilever ($HINDUNILVR)14.0%15.2%16.0%16.6%
 
Median (7 companies)17.6%16.3%16.0%18.6%
Godrej Consumer Products ($GODREJCP)17.8%18.1%15.9%15.5%16.6%


Top companies by CAPEX/Revenue, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Bliss Gvs Pharma ($BLISSGVS)8.7%5.0%16.7%
Colgate-Palmolive (India) ($COLPAL)1.8%3.8%4.9%9.0%
Procter & Gamble Hygiene & Health Care ($PGHH)5.5%4.2%2.2%7.2%
Emami ($EMAMILTD)4.0%8.0%5.0%3.6%
Dabur India ($DABUR)22.7%4.4%3.9%3.0%
 
Median (7 companies)4.7%4.2%4.9%3.6%
Godrej Consumer Products ($GODREJCP)37.8%3.2%4.1%1.8%2.6%


Top companies by ROIC, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Hindustan Unilever ($HINDUNILVR)96.0%99.9%114.4%133.0%
Colgate-Palmolive (India) ($COLPAL)134.8%121.4%120.4%104.4%
Emami ($EMAMILTD)28.2%31.5%36.7%43.3%
Procter & Gamble Hygiene & Health Care ($PGHH)25.2%28.1%30.3%43.2%
Dabur India ($DABUR)36.5%29.4%28.7%30.8%
 
Median (9 companies)27.1%28.7%30.3%30.8%
Godrej Consumer Products ($GODREJCP)25.5%19.1%17.4%17.7%18.8%


Top companies by Net Debt / EBITDA

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Bliss Gvs Pharma ($BLISSGVS)0.0x1.1x1.9x
Cupid ($CUPID)2.2x1.7x0.5x1.4x
Marico ($MARICO)1.4x1.5x1.3x0.9x
Dabur India ($DABUR)1.0x0.8x1.2x0.3x
Hindustan Unilever ($HINDUNILVR)-0.6x-0.3x-0.1x-0.2x
 
Median (8 companies)0.6x0.5x0.2x0.1x
Godrej Consumer Products ($GODREJCP)2.7x1.6x1.7x1.5x1.7x